1. Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study 
M. Tamm, T. Todisco, C. Feldman, J. Garbino, F. Blasi, P. Hogan, P.J. de Caprariis, I.M. Hoepelman 
Clinical Microbiology and Infection 
Volume 13, Issue 2, Pages (February 2007)
DOI: /j x
Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions

2. FIG. 1
Clinical success at end of therapy (EOT; cure or improvement) and end of study (EOS; cure only) in the clinically evaluable population (one subject infected with an atypical pathogen and a conventional bacterial pathogen was randomised to receive azithromycin but actually received erythromycin).
Clinical Microbiology and Infection  , DOI: ( /j x)
Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions

3. FIG. 2
Mean length of hospital stay for patients in the two treatment groups with an atypical pathogen, or an atypical and a conventional bacterial pathogen, identified during the course of the study.
Clinical Microbiology and Infection  , DOI: ( /j x)
Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions